Ali Güngör

Dr. Ali Güngör

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2026 in Life
Verified
Journal Article
Open access
PDF file
AKAdil Furkan Kılıç
Adil Furkan Kılıç
ESEsra Tuba Sezgin
Esra Tuba Sezgin
GHGulbaniz Huseynova
Gulbaniz Huseynova
CSCENGİZ SARIGÜL
CENGİZ SARIGÜL
MÖMustafa Özkaraca
Mustafa Özkaraca
OCOrhan Cimen
Orhan Cimen
Background: Immune checkpoint inhibitors (ICIs), particularly programmed death-ligand 1 (PD-L1) inhibitors such as atezolizumab, have significantly improved outcomes in cancer therapy. However, these agents may cause immune-related adverse effects, including nephrotoxicity associated with oxidative stress and cellular stress responses. This study aimed to investigate and comparatively evaluate the protective effects of adenosine triphosphate (ATP) and taxifolin against atezolizumab-induced renal tissue injury in rats. Methods: Animals were divided into four groups: healthy (HG), atezolizumab (ATZ), ATP + atezolizumab (ATAZ), and taxifolin + atezolizumab (TXAZ). ATP (4 mg/kg, i.p.) and taxifolin (50 mg/kg, oral) were administered for six days, while atezolizumab (10 mg/kg, i.p.) was given on days 1 and 4. On day 7, renal tissues were collected for biochemical, histopathological, and double immunofluorescence analyses. Results: Atezolizumab significantly increased malondialdehyde (MDA) levels and decreased total glutathione (tGSH), superoxide dismutase (SOD), and catalase (CAT) levels, indicating enhanced oxidative stress and impaired antioxidant defense. These changes were accompanied by tubular degeneration and increased expression of apoptotic markers. Both ATP and taxifolin significantly ameliorated these alterations; however, ATP demonstrated a more pronounced protective effect. Conclusions: In conclusion, ATP and taxifolin attenuated the biochemical, histopathological, and immunofluorescence alterations associated with atezolizumab administration. ATP exhibited a more pronounced protective effect than taxifolin under the conditions of this experimental model. Nevertheless, further experimental studies are required to elucidate the mechanisms underlying these effects.

Verified
Journal Article
Open access
PDF file
SBSeval Bulut
Seval Bulut
DADurdu Altuner
Durdu Altuner
BSBahadir Suleyman
Bahadir Suleyman
RMRenad Mammadov
Renad Mammadov
MÖMustafa Özkaraca
Mustafa Özkaraca
HSHalis Suleyman
Halis Suleyman
Erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), is widely used in cancer therapy; however, hepatotoxicity limits its clinical use. This study investigated the protective effects of Liv-52, a polyherbal hepatoprotective formulation, against erlotinib-induced hepatotoxicity in rats and compared its efficacy with melatonin. The animals (n = 24, Wistar albino rats) were randomly categorized into four groups: healthy (HG), erlotinib (ERG), Liv-52 + erlotinib (LEG), and melatonin + erlotinib (MEG). Liv-52 (50 mg/kg/day, orally) and melatonin (10 mg/kg/day, orally) were administered once daily for two weeks. Erlotinib (10 mg/kg, orally) was given every other day to ERG, LEG, and MEG groups for two weeks. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) were measured. Hepatic malondialdehyde (MDA), total glutathione (tGSH), superoxide dismutase (SOD), and catalase (CAT) levels were analyzed. Additionally, double immunofluorescence staining was performed to evaluate apoptotic (poly[ADP-ribose] polymerase-1 [PARP-1], apoptosis-inducing factor [AIF]), inflammatory (cyclooxygenase-2 [COX-2]), and anti-inflammatory (interleukin-10 [IL-10]) biomarkers in liver tissues. Histopathological examination was also conducted to assess structural alterations. Erlotinib significantly increased MDA, ALT, AST, and LDH while decreasing tGSH, SOD, and CAT (p < 0.001). Strong immunoreactivity for PARP-1, AIF, IL-10, and COX-2, as well as severe hydropic degeneration and necrosis, was observed in ERG (p < 0.05). Both Liv-52 and melatonin significantly ameliorated biochemical, histopathological, apoptotic, and inflammatory alterations (p < 0.05). Notably, Liv-52 demonstrated superior hepatoprotective efficacy compared to melatonin. These findings indicate that Liv-52 effectively attenuates erlotinib-induced hepatotoxicity by modulating oxidative stress, inflammatory responses, and apoptotic pathways, thereby preserving liver function and structural integrity.

27 May 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
EHEngin Hendem
Engin Hendem
BYBulent Yavuzer
Bulent Yavuzer
ESEsra Tuba Sezgin
Esra Tuba Sezgin
MGMurat Gunay
Murat Gunay
MÖMustafa Özkaraca
Mustafa Özkaraca
HSHalis Suleyman
Halis Suleyman
Background: Pembrolizumab, a programmed cell death protein 1 (PD-1) inhibitor, is widely employed in oncological practice; however, its propensity to induce nephrotoxicity through immune-mediated oxidative and inflammatory mechanisms remains an insufficiently characterized clinical concern. The present study comparatively investigated the renoprotective effects of flunarizine, a voltage-dependent calcium channel antagonist, and carvacrol, a monoterpene, against pembrolizumab-induced renal injury in rats. Methods: Twenty-four male Wistar albino rats were assigned to four groups (n = 6): healthy control (HG), pembrolizumab alone (PZB), flunarizine+pembrolizumab (FLPZ), and carvacrol+pembrolizumab (CCPZ). Pembrolizumab was administered intraperitoneally at 5 mg/kg; flunarizine orally at 5 mg/kg and carvacrol intraperitoneally at 50 mg/kg, once daily for seven consecutive days. Renal oxidative status was assessed by measuring malondialdehyde (MDA) and total glutathione (tGSH) levels. Histopathological evaluation was performed using hematoxylin and eosin staining. Two double immunofluorescence panels were employed to assess 3,3′-dityrosine/Hepatitis A virus cellular receptor 1 (HAVCR1) and cyclooxygenase-1 (COX-1)/cyclooxygenase-2 (COX-2) expression, respectively. Results: Pembrolizumab caused pronounced oxidative stress and inflammatory responses in renal tissue, leading to a significant increase in renal MDA levels and a marked decrease in tGSH levels. These biochemical alterations were accompanied by severe tubular degeneration and increased expression of 3,3′-dityrosine, which is associated with oxidative damage, as well as HAVCR1, a marker of cellular injury, and COX-1 and COX-2, which reflect inflammatory activity. These findings indicate that pembrolizumab disrupts the renal redox balance and activates both oxidative and inflammatory pathways in kidney tissue. Flunarizine and carvacrol significantly reduced these pathological changes. Both agents attenuated oxidative stress markers and supported antioxidant defenses, thereby alleviating tissue damage. However, flunarizine demonstrated a more pronounced renoprotective effect across all evaluated parameters, restoring MDA and tGSH levels closer to physiological values and reducing tubular injury to a minimal level. Carvacrol showed a more limited but still statistically significant protective effect. Conclusions: Both agents confer significant renoprotection against pembrolizumab-induced oxidative injury; however, flunarizine exhibits a more robust protective profile, likely attributable to its capacity to attenuate calcium-mediated mitochondrial dysfunction and preserve cellular bioenergetic homeostasis.

4 June 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
SCSerkan Cerrah
Serkan Cerrah
ABAhmed Ramiz Baykan
Ahmed Ramiz Baykan
ESEsra Tuba Sezgin
Esra Tuba Sezgin
GHGulbaniz Huseynova
Gulbaniz Huseynova
EKElif Karabacak
Elif Karabacak
HSHalis Suleyman
Halis Suleyman
Objective: Linezolid (LZD), an oxazolidinone antibiotic widely used against Gram-positive infections, has been associated with mitochondrial dysfunction and hepatotoxicity, particularly during prolonged use. This study aimed to investigate the protective effects of adenosine triphosphate (ATP) and Liv-52 against LZD-induced liver injury, with a focus on oxidative stress, inflammation, and necroptosis pathways. Methods: Twenty-four male Wistar rats were randomly assigned to four groups: healthy control (HG), LZD-treated (LZDG), Liv-52 + LZD (LVLZ), and ATP + LZD (ATLZ). Liv-52 (50 mg/kg, orally) and ATP (5 mg/kg, intraperitoneally) were administered prior to LZD (125 mg/kg, orally) for 14 days. Results: Following LZD administration, malondialdehyde (MDA) levels markedly increased, indicating oxidative stress, while total glutathione (tGSH), superoxide dismutase (SOD), and catalase (CAT) activities significantly decreased. Histopathological examination revealed pronounced hepatocellular damage accompanied by increased NF-κB, NLRP3, RIPK3, and MLKL expression, indicating activation of inflammatory and necroptotic pathways. Treatment with ATP and Liv-52 significantly ameliorated these biochemical, histopathological, and molecular alterations. Conclusions: Treatment with ATP and Liv-52 significantly attenuated oxidative stress, improved histopathological alterations, and suppressed the expression of inflammatory and necroptotic markers. Notably, ATP exhibited a more pronounced protective effect compared to Liv-52. In conclusion, LZD induces hepatotoxicity through oxidative stress-mediated inflammatory and necroptotic mechanisms, while ATP and Liv-52 confer hepatoprotection, with ATP showing superior efficacy.

1 January 2026
Verified
Journal Article
Open access
PDF file
AAAyhan Atasever
Ayhan Atasever
AGAli Güngör
Ali Güngör
MÖMustafa Özkaraca
Mustafa Özkaraca
MTMehmet Özkan Timurkan
Mehmet Özkan Timurkan
TTTurhan Turan
Turhan Turan
The aim of this study was to investigate the presence of bovine herpesvirus type 1 and bovine parainfluenza virus type 3 (PI-3) in cattle lungs exhibiting pneumonia symptoms observed during macroscopic examination. Polymerase chain reaction, double immunohistochemistry, and double immunofluorescence methods were used for viral detection. For this purpose, during the summer-autumn period of 2023, a total of 84 lung samples from cattle aged 1 year and older, exhibiting macroscopic signs of pneumonia, were collected in Kayseri province, Türkiye. Pneumonia lesions were recorded according to the anatomical locations. In virus detection, PI-3 was identified at a rate of 8.33% using double immunohistochemistry/immunofluorescence staining methods, while this rate was found to be 6.72% in polymerase chain reaction. Bovine herpesvirus type 1 was not detected by any of the three methods. In the cattle lungs, 44 lesions (52.38%) were detected in the apical lobe, while seven lesions (8.33%) were detected in the middle lobe, eight lesions (9.52%) in the accessory lobe, and 25 lesions (29.76%) in the basal lobe. The PI-3 immunopositivity was observed in alveolar epithelial cells, as well as mononuclear cells in the interstitial and peri-vascular regions. This study is the first to examine bovine herpesvirus type 1 and PI-3 presence in bovine lungs using three distinct validation techniques (polymerase chain reaction, double immunohistochemistry, and double immunofluorescence).

28 March 2025 in Doğu Karadeniz Sağlık Bilimleri Dergisi
Verified
Journal Article
Open access
PDF file
AGAli Güngör
Ali Güngör
Aujeszky hastalığı, ya da diğer adıyla Pseudorabies, Suid Alphaherpesvirus 1 tarafından oluşturulan ve domuzlar başta olmak üzere birçok memeli hayvanda enfeksiyonlara yol açan viral bir hastalıktır. Pseudorabies virüsü, Herpesviridae ailesinin Alphaherpesvirinae alt ailesine ait olup, domuzlar bu virüsün doğal konakçısıdır. Enfeksiyon, özellikle domuz yavrularında nörolojik bozukluklara, erişkin dişi domuzlarda ise infertiliteye neden olmaktadır. Virüs, sinir sistemi aracılığıyla yayılarak, enfekte hayvanlar arasında ağız ve burun salgıları yoluyla doğrudan temasla bulaşmaktadır. Aujeszky hastalığı, dünya genelinde büyük ekonomik kayıplara yol açmakta ve özellikle Latin Amerika, Afrika, Asya ve Doğu Avrupa gibi bölgelerde yaygın olarak görülmektedir. Bu derleme makale, Pseudorabies virüsünün etiyolojik özelliklerini, patogenezini, klinik bulgularını, epidemiyolojik yayılımını ve kontrol yöntemlerini incelemektedir.